Objectives: Allergic rhinitis (AR) is increasingly recognized as a systemic inflammatory condition. While symptom scores are commonly used for disease monitoring, objective biomarkers to predict treatment outcomes remain limited. This study evaluated systemic inflammatory indices (neutrophil-to-lymphocyte ratio [NLR], platelet-to-lymphocyte ratio [PLR], systemic immune-inflammation index [SII], eosinophil count, and total immunoglobulin E [IgE]) as biomarkers in AR over 6 month follow-up. Methods: This prospective cohort study enrolled 105 patients with moderate-to-severe persistent AR and 92 matched healthy controls. Baseline and 6 month measurements included complete blood count–derived indices and total serum IgE. Symptom severity was assessed using Total Nasal Symptom Score and visual analog scales. ROC analyses determined optimal cutoff values for predicting treatment response. Results: At baseline, AR patients had significantly-higher NLR, PLR, SII, and eosinophil counts than controls (all P < .001). These indices declined significantly in parallel with symptom improvement. Baseline NLR >2.7 showed the strongest predictive value for nonresponse (sensitivity 84%, specificity 76%, OR 4.2). PLR >240, SII >1100, eosinophils >600/µL, and IgE >450 IU/mL were also associated with increased nonresponse risk. Total IgE remained stable and was not useful for short-term monitoring. A mixed-effects longitudinal model confirmed that reductions in NLR, PLR, and eosinophil count were significantly greater in AR patients than in controls, supporting that these biomarker changes were treatment related. Conclusion: NLR, PLR, SII, and eosinophil count are promising biomarkers for monitoring disease activity and predicting treatment response in AR. NLR may serve as a simple, cost-effective tool for early risk stratification. These findings support integrating routine hematologic markers into clinical management of AR.
1 January 2026 in International Archives of Otorhinolaryngology
Recurrent laryngeal nerve (RLN) paralysis is a distressing complication of thyroidectomy, and many methods have been investigated for prevention. The aim of our study is to investigate to what extent intraoperative neuromonitoring (IONM) predicts postoperative RLN paralysis and what factors may be causing it. Patients who underwent thyroidectomy in our clinic between January 2014 and December 2020 were included. Patient diagnoses, demographic characteristics, laboratory and imaging results, surgical information, and IONM results were evaluated. Data from 287 patients and 523 RLNs were evaluated. Twenty-two (4.2%) of the RLNs were paralytic. The rate of paralysis was significantly higher in total thyroidectomies than in lobectomies (p = 0.046), permanent paralysis rate was higher in left RLNs. Malignancy was statistically associated with permanent paralysis (p = 0.017). The rate of overall and permanent paralysis was higher in patients with negative results of first, second response, first, and second laryngeal twitch examinations. The means of the first and second responses of the paralyzed RLNs were lower (p = 0.016, p < 0.01, respectively). The sensitivity of the IONM increased when the new thresholds of the first and second responses were determined to be 155 and 170 µv, respectively, by ROC analysis. This study demonstrates that voltage variation and magnitude obtained from IONM can be predictive and sensitivity can be increased by using a threshold higher than 100 µV and patients in this range may be at risk for RLN paralysis. Our results may guide future studies of IONM and risk scoring systems to be developed for RLN paralysis.
25 December 2024 in Turkish Journal of Biochemistry
Objectives: D-dimer molecules are formed as a result of fibrinolysis and elevation of D-dimer levels are suggestive for thrombosis. The elevation of D-dimer levels and its correspondence with thromboembolism in orthopedic and general surgeries are well studied, but there are only a few studies in literature that investigates this issue in head and neck surgery. We aimed to investigate D-dimer levels and its course throughout the perioperative period in patients who underwent head and neck cancer surgery. Methods: We conducted a prospective, observational study in patients who underwent neck dissection along with primary tumor resection in our otorhinolaryngology clinic between January 2022 and June 2023. D-dimer levels were measured from blood samples preoperatively and postoperatively days 0–7 and on postoperative 14th day. D-dimer levels were compared statistically. Results: Twenty-one patients were included in the study. D-dimer values peaked on the first day then gradually decreased and reached a level slightly below 2 times of the preoperative values on the 14th day. The change in D-dimer levels between preoperative and postoperative days 1–14 was statistically significant. The difference between D-dimer levels measured on each day of the first week and levels on 14th day was found to be significant. Also, difference of D-Dimer levels between postoperative day 0 and day 7 was statistically significant. Conclusions: The trend of D-dimer levels following surgery in head and neck cancer patients may prove useful in clinical practice to rule out thrombotic events, in accordance with other risk factors and symptomatology.